ExodusPoint Capital Management’s Intersect ENT, Inc XENT Stock Holding History

ExodusPoint Capital Management’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-43,152	Closed	-$1.21M	–	2757
2022 Q1	$1.21M	Buy	+43,152	New	+$1.18M	0.02%	1044
2021 Q3	–	Sell	-18,440	Closed	-$315K	–	2873
2021 Q2	$315K	Buy	+18,440	New	+$345K	﹤0.01%	1716
2021 Q1	–	Sell	-142,192	Closed	-$3.26M	–	2783
2020 Q4	$3.26M	Buy	142,192 +48,300	+51%	+$920K	0.03%	373
2020 Q3	$1.53M	Buy	93,892 +71,313	+316%	+$1.29M	0.03%	496
2020 Q2	$306K	Buy	+22,579	New	+$263K	0.01%	1310

ExodusPoint Capital Management's XENT Position: Q2 2022 in Review

ExodusPoint Capital Management sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 43,152 shares — an estimated $1.21M sold.

ExodusPoint Capital Management first reported a position in XENT in Q2 2020 and held it in 5 quarters. The position peaked at $3.26M in Q4 2020. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

ExodusPoint Capital Management reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
ExodusPoint Capital Management sold 43,152 Intersect ENT, Inc shares in Q2 2022, an estimated $1.21M.
ExodusPoint Capital Management first reported a position in Intersect ENT, Inc in Q2 2020 and held it in 5 quarters.
ExodusPoint Capital Management's Intersect ENT, Inc position peaked at $3.26M in Q4 2020.
0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on ExodusPoint Capital Management's 13F filing for Q2 2022, filed 22 Aug 2022.